639 |
CTO: Personal Experience in the Retrograte Approach |
Jacques J. Koolen |
Jun. 05. 09 |
638 |
Recent Pogress of CTO and Long Term Durability of DES for CTO |
Sunao Nakamura |
Jun. 05. 09 |
637 |
Rationale for Chronic Total Occlusion Revsacularization |
David E. Kandzari |
Jun. 05. 09 |
636 |
The ENABLER-P: A Novel CTO Crossing System, Report of First in Human Experience- Peripheral Arteries |
Maurice Buchbinder |
Jun. 05. 09 |
635 |
Most Advanced Strategy for Coronary CTO |
Etsuo Tsuchikane |
Jun. 05. 09 |
634 |
Clinical Application of OCT |
Junya Shite |
Jun. 04. 09 |
633 |
Drug Eluting Stent Cell Size and Bifurcational Stenting Techniques Used |
Lei Ge |
Jun. 04. 09 |
632 |
Stent Thrombosis in Bifurcation Stenting |
Huay Cheem Tan |
Jun. 04. 09 |
631 |
When and How to Treat Side Branch in Provisional Stenting |
Angela Hoye |
Jun. 04. 09 |
630 |
Current Development and Next-Generation of OCT |
Ik-Kyung Jang |
Jun. 04. 09 |